Placental pathology in systemic lupus erythematosus: A prospective study

OBJECTIVES: Systemic lupus erythematosus and antiphospholipid antibody, often identified in patients with systemic lupus erythematosus, are associated with poor pregnancy outcome. This study distinguishes between the effect of each of these factors on gestational outcome and placental pathologic con...

Full description

Saved in:
Bibliographic Details
Published inAmerican journal of obstetrics and gynecology Vol. 179; no. 1; pp. 226 - 234
Main Authors Magid, Margret S., Kaplan, Cynthia, Sammaritano, Lisa R., Peterson, Margaret, Druzin, Maurice L., Lockshin, Michael D.
Format Journal Article
LanguageEnglish
Published Philadelphia, PA Mosby, Inc 01.07.1998
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:OBJECTIVES: Systemic lupus erythematosus and antiphospholipid antibody, often identified in patients with systemic lupus erythematosus, are associated with poor pregnancy outcome. This study distinguishes between the effect of each of these factors on gestational outcome and placental pathologic conditions in pregnant patients with systemic lupus erythematosus. STUDY DESIGN: Thirty-seven pregnancies and 40 placentas from 33 women with systemic lupus erythematosus were studied prospectively. RESULTS: Systemic lupus erythematosus alone, but not systemic lupus erythematosus activity, was associated with increased spontaneous abortions, preterm gestations, and fetal growth restriction. Placental correlates were ischemic-hypoxic change, decidual vasculopathy, decidual and fetal thrombi, chronic villitis, and decreased placental weight. Extensive infarction and fetal death were important antiphospholipid antibody–related findings. CONCLUSIONS: Decidual vasculopathy/coagulopathy appears to mediate the antiphospholipid antibody–related and much of the systemic lupus erythematosus–related deleterious effect on the placenta and gestational outcome. The presence of antiphospholipid antibody largely, but not invariably, predicts fetal death. Antiphospholipid antibody–independent chronic villitis may represent a second mechanism of systemic lupus erythematosus–related change. (Am J Obstet Gynecol 1998;179:226-34.)
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:0002-9378
1097-6868
DOI:10.1016/S0002-9378(98)70277-7